COVID-19, The Continued BC-CfE Response

Dr. Julio Montaner
Executive Director & Physician-in-Chief
BC Centre for Excellence in HIV/AIDS
 
Dr. Peter Phillips
Clinical Professor
Division of Infectious Diseases, University of British Columbia
 
Dr. Zabrina Brumme and Dr. Chanson Brumme
Laboratory Director and Assistant Director, Research Laboratories
Laboratory Program
BC Centre for Excellence in HIV/AIDS
 
Dr. Junine Toy, Pharm D
Senior Manager, BC Centre for Excellence in HIV/AIDS Drug Treatment Program
Clinical Pharmacy Specialist, St. Paul’s Hospital
Share this video:
Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025